VANCOUVER, British Columbia (GenomeWeb) – At the American Society of Human Genetics annual meeting here yesterday, the BC Cancer Agency's Marco Marra shared his team's experiences with the first few hundred adult and pediatric cancer cases assessed through the ongoing Personalized Oncogenomics (POG) clinical trial.

Speaking as part of an Illumina-sponsored workshop at the conference, Marra noted that roughly 700 individuals have been enrolled in POG since the main project began in 2015, with more than 400 adult cases and nearly three-dozen pediatric cases sequenced so far.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Jackson Laboratory has filed a complaint accusing Nanjing University of breeding and re-selling its mouse models, the Hartford Courant reports.

Oxford researchers are turning to virtual reality to visualize genes and regulatory elements, says.

In Science this week: neutrophils rely on microRNA to protect against lung inflammation, and more.

China is moving forward with plans to sequence a million citizens, the Wall Street Journal reports.

Sponsored by
Philips Genomics

This webinar will present an in-depth look at how Memorial Sloan Kettering Cancer Center has developed and implemented a next-generation sequencing panel for mutational tumor profiling of advanced cancer patients.

Sponsored by

This webinar will be a roundtable discussion on the adoption of a commercial gene panel for tumor profiling at several leading US cancer centers. 

Sponsored by
Cofactor Genomics

This webinar will discuss the benefits of genomically profiling the immune microenvironment of soft tissue sarcomas during neoadjuvant therapy.